JABSOM Cell and Molecular Biology researcher Dr. Jesse Owens has spent the better part of two decades chasing a vision that ...

Researchers have developed a new "color-coded" genetic method that makes it easy to distinguish male and female mosquitoes.

Adult neurogenesis, the process by which Neural Stem Cells (NSCs) generate new neurons in the mature brain, is increasingly recognized as a dynamic ...

What keeps our cells the right size? Scientists have long puzzled over this fundamental question, since cells that are too large or too small are linked to many diseases. Until now, the genetic basis ...

In October, Poethig and fellow researcher Aaron Leichty — a former graduate student in Poethig’s lab — published research on ...

Daily orange juice has long been sold as a simple breakfast habit, but new research suggests it may be doing far more than topping up vitamin C. Scientists now report that a regular glass could ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Novartis AG’s (NYSE: NVS) Itvisma (onasemnogene abeparvovec-brve) for children two years and older, teens, and adults with spinal ...

What Is Itvisma, and Why Does It Matter? Itvisma (onasemnogene abeparvovec-brve) is a gene therapy that the FDA has approved to treat spinal muscular atrophy (SMA) in adults, teens, and children 2 or ...

FDA approved Itvisma, a gene therapy for SMA patients aged 2 and older. Itvisma delivers a healthy SMN1 gene via spinal injection in a one-time treatment. This expands gene therapy access to older ...

The Food and Drug Administration on Monday approved a new version of Novartis’ gene therapy for spinal muscular atrophy, aimed at children over the age of 2, teens and adults with less severe forms of ...